Gregory Bailey Age X Therapeutics, Inc. (AGE) insider trading activity

Gregory Bailey is Director of AgeX Therapeutics, Inc.. Currently has a direct ownership of 67,243 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Dec 17, 2024, when has been sold 3,866 shares (Common Stock) at a price of $4.59 per share, resulting in proceeds of $17,744. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.2K

6.1% 3M change

n/a 12M change

Total Value Held $0

Gregory Bailey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 17 2024	BUY Open market or private purchase	$17,744 $4.59 p/Share	3,866 Added 5.44%	67,243 Common Stock
Sep 20 2024	BUY Open market or private purchase	$6,856 $6.03 p/Share	1,137 Added 1.76%	63,377 Common Stock
Sep 19 2024	BUY Open market or private purchase	$71,358 $6.11 p/Share	11,679 Added 15.8%	62,240 Common Stock
Sep 18 2024	BUY Open market or private purchase	$16,877 $6.23 p/Share	2,709 Added 5.09%	50,561 Common Stock
Aug 20 2024	BUY Open market or private purchase	$14,652 $8.25 p/Share	1,776 Added 3.6%	47,582 Common Stock
Aug 19 2024	BUY Open market or private purchase	$50,752 $7.93 p/Share	6,400 Added 12.26%	45,806 Common Stock
Aug 16 2024	BUY Open market or private purchase	$46,784 $7.31 p/Share	6,400 Added 13.97%	39,406 Common Stock
Aug 15 2024	BUY Open market or private purchase	$42,560 $6.65 p/Share	6,400 Added 16.24%	33,006 Common Stock
Aug 14 2024	BUY Open market or private purchase	$45,248 $7.07 p/Share	6,400 Added 19.39%	26,606 Common Stock
May 30 2024	BUY Open market or private purchase	$49,447 $9.5 p/Share	5,205 Added 20.48%	20,206 Common Stock
May 29 2024	BUY Open market or private purchase	$11,143 $9.5 p/Share	1,173 Added 7.25%	15,001 Common Stock
May 28 2024	BUY Open market or private purchase	$85,680 $9.5 p/Share	9,019 Added 39.48%	13,828 Common Stock
May 23 2024	BUY Open market or private purchase	$22,524 $9.5 p/Share	2,371 Added 33.02%	4,809 Common Stock
May 21 2024	BUY Open market or private purchase	$8,702 $9.5 p/Share	916 Added 27.31%	2,438 Common Stock
May 21 2024	BUY Open market or private purchase	$13,509 $9.5 p/Share	1,422 Added 48.3%	1,522 Common Stock
May 20 2024	BUY Open market or private purchase	$900 $9.0 p/Share	100 Added 50.0%	100 Common Stock

Also insider at

BHVN

Biohaven Pharmaceutical Holding Co Ltd. Healthcare

BHVN

Biohaven Ltd.

Director

Gregory Bailey

Director

New Haven, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGE shares.

Notify only if

Value

Insider Trading

Get notified when an Age X Therapeutics, Inc. insider buys or sells AGE shares.

Notify only if

Operation

Value

Type

News

Receive news related to AgeX Therapeutics, Inc.

Track Activities on AGE

Account